BUSINESS
If Rouhani's COVID-19 numbers are true, Iran is heading for herd immunity
So what this possibly means is that Iran may not need a COVID-19 vaccine - generally considered as fastest and surest way to reach herd immunity.
BUSINESS
Exclusive | Zydus Cadila expects to launch Remdesivir in August: Chairman Pankaj Patel
Chairman Pankaj Patel said Zydus Cadila has potential to produce as high as 3-4 lakh doses a month.
BUSINESS
Pankaj Patel expects Zydus Cadila's potential COVID-19 vaccine to hit market by early 2021
"We are expecting the phase-1 and phase-2 studies to be completed in 3 months," Pankaj Patel said in an interview to Moneycontrol.
BUSINESS
COVID-19 treatment | Zydus Cadila gets Mexican drug regulator’s nod to test PegInterferon alfa-2b
Pegylated Interferon alfa-2b, is an old drug sold by Zydus under brand name PegiHepTM in India since 2011 for the treatment of Hepatitis B and C with 1.5 lac doses being administered.
BUSINESS
Explained: Why is Biocon's COVID-19 drug Itolizumab kicking up a controversy?
The critics are pointing to the small size of the clinical trial, exemption of Phase-3 trial, use of the drug as off-label for COVID-19, and making claims to the press before data is published in a peer-reviewed journal.
BUSINESS
Zydus Cadila begins human trials of its potential vaccine for coronavirus
The company said that Zydus has already manufactured clinical GMP batches of the vaccine candidate and plans to initiate the clinical trials in July 2020 across multiple sites in India in over 1000 subjects.
BUSINESS
Rising inventory, falling prices spook PPEs, sanitizer makers who jumped into COVID-19 bandwagon
According to Association of Indian Medical Device Industry (AiMeD) The capacity before onset of COVID-19 pandemic was 6.24 million units per annum to 250.98 million pieces per annum which is 43 times by end of by end of June.
BUSINESS
Biocon's partner Equillium plans Itolizumab's global clinical trial for COVID-19
Biocon has out-licensed Itolizumab to US-based biotech firm Equillium in 2017 for development in the US and Canada. Equillium has been awarded ‘fast track’ and ‘orphan drug’ designations for the molecule in both prevention and treatment of graft-versus-host disease by the USFDA.
BUSINESS
Coronavirus treatment | Cipla ramps up remdesivir capacity to meet surge in demand
Cipla also launched a dedicated 24x7 helpline and email channel to support patient access to these critical drugs exclusively during this pandemic outbreak.
BUSINESS
Pharma wrap: WHO adds airborne transmission to modes of coronavirus spread; but is it coming too late?
Airborne transmission allows a virus to enter the upper and lower respiratory tracts.
BUSINESS
Ajay Piramal says liquidity isn't a problem for good NBFCs
Piramal sees a 'U' shaped one, which is more gradual than a 'V' shaped recovery
BUSINESS
Indian pharma market contracts nearly 6% in Q1FY21
Chronic segment that includes drugs for cardiovascular, diabetes, and neuro saw a slump in sales in Q1FY21 due to pre-emptive buying in March
BUSINESS
Bharat Biotech COVID-19 vaccine: Testing underway at CDL-Kasauli, volunteer enrolment begins
Once CDL clears the batches, the vaccine candidate will be given to human volunteers within a day or two as part of Phase I and II human clinical trials.
BUSINESS
COVID-19 vaccine: Premas Biotech initiates mice studies
The company said it had successfully completed the manufacturing process for the VLP (virus like particle) vaccine candidate, which includes three surface antigens from SARS-CoV-2.
BUSINESS
Japanese drugmaker Takeda launches gastrointestinal drug Vedolizumab in India
Kynteles which is sold globally as Entyvio in more than 60 countries, generated sales of $3.2 billion in FY20.
BUSINESS
Johnson & Johnson cuts price of TB drug Bedaquiline by 32%
The World Health Organisation (WHO) recommends the oral drug Bedaquiline as the backbone of DR-TB treatment, to replace older, more toxic drugs that have to be injected daily and can cause intolerable side effects, such as deafness
BUSINESS
Why top scientist Gagandeep Kang's sudden exit raises eyebrows?
Kang cited ‘personal reasons’ for her resignation, and dismissed speculation linking her resignation with government disbanding a committee headed by her to look into indigenous COVID-19 drugs and vaccines
BUSINESS
Hetero facilitates COVID-19 patients to access their remdesivir version
Patients who are in need of the drug will have to fill details such as Name, email, location, contact, number, and quantity, provided on the product enquiry page on Hetero website.
BUSINESS
Explained: How did Bharat Biotech emerge as dark horse in race for COVID-19 vaccine?
ICMR and Bharat Biotech are jointly working on the pre-clinical as well as clinical development of the vaccine.
BUSINESS
Bharat Biotech's COVID-19 vaccine gets DCGI nod to conduct human trials
Bharat Biotech is developing COVID-19 vaccine in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), Pune.
BUSINESS
COVID-19 vaccine demand | Have sufficient vials capacity: Companies
Health experts globally are concerned whether there would be enough glass-vials available to pack billion of COVID-19 vaccine doses.
BUSINESS
Social distancing, wearing face masks need to be pushed with vigour as COVID-19 cases rise
As COVID-19 cases continue to rise in India, social distancing and practice of wearing a mask in public need to be enforced with vigour.
BUSINESS
Piramal says Carlyle proceeds will help fund pharma acquisitions, organic growth
The company said it is looking at a range of pharma assets in India and abroad that include branded formulations, manufacturing sites, complex hospital generics and even possibly entering vaccines.
BUSINESS
Thermo Fisher Scientific ramping up COVID-19 test kits capacity, reopens Indian factories
scaled up global production of RT-PCR test kits from 50 thousand to 10 million a week.
